ORLISTAT vs OSIMERTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ORLISTAT vs OSIMERTINIB: Safety Overview
| Metric | ORLISTAT | OSIMERTINIB |
|---|---|---|
| Total FAERS Reports | 6,498 | 27,750 |
| Deaths Reported | 31 | 12,456 |
| Death Rate | 0.5% | 44.9% |
| Hospitalizations | 329 | 5,277 |
| Average Patient Age | 49.0 yrs | 68.2 yrs |
| % Female Patients | 83.9% | 66.0% |
| FDA Approval Date | Apr 23, 1999 | Nov 13, 2015 |
| Manufacturer | H2-Pharma LLC | AstraZeneca Pharmaceuticals LP |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |